Table 5 Healthcare interventions received during the course of antenatal consultations
Interventions | SulfadoxinePyrimethamine %(n = 1631) | Iron % (n = 1631) | Folic acid %(n = 1631) | ITN %(n = 1631) | Mebendazole %(n = 1631) | Tetanus vaccine %(n = 1631) | Test for HIV % (n = 1631) |
|---|---|---|---|---|---|---|---|
Coverage | 32.7 | 35.6 | 29.2 | 12.8 | 38.1 | 60.6 | 15.5 |
95%CI | 30.4–35.0 | 33.3-38.0 | 27.0 – 31.5 | 11.2 – 14.5 | 35.7-40.5 | 58.2-63.0 | 13.8-17.4 |
Start (months) | (n = 533) | (n = 580) | (n = 476) | (n = 209) | (n = 621) | (n = 988) | (n = 253) |
1 | 0.0 | 2.8 | 3.2 | 25.8 | 1.9 | 2.2 | 4.0 |
2 | 0.0 | 6.7 | 4.2 | 6.7 | 6.0 | 5.3 | 4.0 |
3 | 16.1 | 11.5 | 13.4 | 20.2 | 11.2 | 14.4 | 14.7 |
4 | 19.3 | 17.0 | 18.1 | 13.5 | 16.2 | 17.1 | 17.3 |
≥5 | 64.6 | 62.0 | 61.1 | 33.7 | 64.7 | 61.1 | 60.0 |
Frequency (dose) | |||||||
1 | 62.1 | 82.9 | 57.2 | ||||
2 | 37.9 | 17.1 | 42.8 |